PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33834669-9	2021	Sitagliptin suppressed 5 microg mL-1 of LPS-induced IL-6, IL-8, CCL2, and SOD2 gene expression levels in HGF in a concentration-dependent manner.	Sitagliptin Phosphate	0-11	C-X-C motif chemokine ligand 8	Homo sapiens	58-62	
34967261-8	2022	Sitagliptin inhibited HG-induced production of pro-inflammatory cytokines interleukin-1beta (IL-1beta) and interleukin-8 (IL-8) in HrGECs.	Sitagliptin Phosphate	0-11	C-X-C motif chemokine ligand 8	Homo sapiens	107-120	
34967261-8	2022	Sitagliptin inhibited HG-induced production of pro-inflammatory cytokines interleukin-1beta (IL-1beta) and interleukin-8 (IL-8) in HrGECs.	Sitagliptin Phosphate	0-11	C-X-C motif chemokine ligand 8	Homo sapiens	122-126	
33834669-10	2021	Furthermore, sitagliptin significantly decreased the elevated secretion of IL-6, IL-8, and CCL2 protein induced by LPS.	Sitagliptin Phosphate	13-24	C-X-C motif chemokine ligand 8	Homo sapiens	81-85	
33834669-12	2021	Results of qRT-PCR analysis indicated that 0.5 micromol L-1 of sitagliptin and 5 micromol L-1 of BAY11-7082 significantly inhibited LPS-induced IL-6, IL-8, CCL2, and SOD2 gene expressions.	Sitagliptin Phosphate	63-74	C-X-C motif chemokine ligand 8	Homo sapiens	150-154	
31105821-6	2019	Notably, our findings indicate that sitagliptin possesses an anti-inflammatory effect against H/R-induced expression of IL-6, IL-8, and TNF-alpha as well as secretion of HMGB1.	Sitagliptin Phosphate	36-47	C-X-C motif chemokine ligand 8	Homo sapiens	126-130	
24559582-9	2014	CONCLUSIONS: Our results suggest that combination therapy with miglitol and sitagliptin improves glycemic control and reduces the circulating protein concentrations of IL-8, sE-selectin, and sVCAM-1 in type 2 diabetic Japanese patients.	Sitagliptin Phosphate	76-87	C-X-C motif chemokine ligand 8	Homo sapiens	168-172